Mar 26, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me Opus Genetics has announced vision improvements for the first three adult patients in its Phase ½ gene therapy clinical trial for Leber congenital amaurosis 5 (LCA5), a rare,...
Dec 11, 2023 | Media, Podcast
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me Laboratoires Théa, the leading European developer of eye care products, has acquired two emerging antisense oligonucleotide (AON) treatments for inherited retinal diseases from...
